Children with medulloblastoma in Bristol are treated surgically and with craniospinal irradiation, and in some cases chemotherapy. Thirteen medium or long term survivors were investigated to determine their growth and endocrine function. Their rate of growth was considerably reduced through the first year of their illness and after spinal irradiation spinal growth was poor. Nine children developed growth hormone deficiency. They were clinically euthyroid but 7 had raised basal thyroid stimulating hormone values. Gonadal function was abnormal in all but the youngest child. The rate of survival is increasing in children with medulloblastoma but this is associated with appreciable endocrine abnormalities. Some of these problems are present shortly after treatment ends but others may develop later and long term surveillance is therefore essential.
tion. [4] [5] [6] The frequency of these problems is unknown.
We report the incidence of delayed growth, disorders of sexual maturation, and endocrine dysfunction in the medium and long term survivors among those children treated in Bristol since 1969 . Patients and methods The age of diagnosis of the 13 children ranged from 4.7 to 13 3 years (mean 9.9 years) (Table) . All the children except 1 had complete or partial removal of the tumour. Radiotherapy was from a cobalt 60 source. It consisted of 50-55 Gy (1 Gy 1=00 rad) to the tumour and 30-35 Gy to the brain and spinal column given in 20-40 fractions over 5-8 weeks, except in the patient in case 1 who received 45 Gy to the tumour and 33 Gy to the spine. The pituitary hypothalamic axis was judged to have received between 41.7 and 48-6 Gy. Radiotherapy was given in a standard manner from 2 lateral fields with beam shaping using lead blocks and direct posterior fields to the spine. Reduced fields were used to give a high dose to the tumour site.
Four patients received adjuvant chemotherapy. Three had vincristine and 1-(2-chloro-thyl)-3-cyclohexyl-l-nitrosurea (CCNU) at 4 weekly intervals for 12 23 In all these series the amount of radiation ranged from 20-40 Gy. We have calculated that our children received a radiation dose to the thyroid of between Gy depending on individual radiotherapy plans, and this has been confirmed using skin dose meters in 1 32 Our data confirm the difficulty in diagnosing partial gonadal damage in mid-childhood but suggest that in the late prepubertal child the FSH response to GnRH may be a more sensitive indicator than the basal FSH value alone. The combined clinical and biochemical data indicate that all but the youngest child have damaged gonads, but that with 1 exception gonadal steroid production is sufficient to allow normal sexual maturation. The biochemical data suggest that their fertility has been impaired though the extent of this is as yet unknown. The youngest child as he grows older may show evidence of similar gonadal problems.
The cause of gonadal damage must be irradiation. Chemotherapy may be an additional hazard for the only child who is agonadal (case 7) had combined radiotherapy and chemotherapy. Furthermore, we have other patients who have had CCNU but no spinal radiotherapy who have evidence of primary gonadal damage, and all 3 drugs used in this study are capable of causing this. 33 Shalet reported ovarian34 and testicular35 damage after abdominal irradiation in childhood. This is influenced not only by the total radiation dose but also by the fractionation and time sequence of treatment and the sex and age of the patient. In women the population of oocytes is finalised at birth and decreases with age. It is not surprising, therefore, that irradiation damage occurs more frequently in older than younger women. However, single doses of 6 Gy are probably 100% effective in inducing permanent sterility in women of all ages.36 Spermatagonia are more susceptible to irradiation than Leydig cells and doses as low as 0 2 Gy in adults may cause temporary sterility, although recovery up to 5 years later has followed doses of over 6 Gy.37 Whether the quiescent prepubertal testis is more or less vulnerable to irradiation is unknown. In this study, after spinal irradiation of 35 Gy the scattered dose to the ovaries may be as high as 10 Gy, and by the use of skin dose meters we have calculated a cumulative dose of approximately 2 4 Gy to the testes.
Prophylactic spinal irradiation is given because of the danger of seeding of medulloblastoma cells to the spine. In 
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